K, S., & BL, D. (2022). Letter to the editor: A reminder to screen for varices! Atezolizumab/bevacizumab for HCC. Hepatology (Baltimore, Md.), 76(4), E78. https://doi.org/10.1002/hep.32556
Chicago Style (17th ed.) CitationK, Suchman, and Da BL. "Letter to the Editor: A Reminder to Screen for Varices! Atezolizumab/bevacizumab for HCC." Hepatology (Baltimore, Md.) 76, no. 4 (2022): E78. https://doi.org/10.1002/hep.32556.
MLA (9th ed.) CitationK, Suchman, and Da BL. "Letter to the Editor: A Reminder to Screen for Varices! Atezolizumab/bevacizumab for HCC." Hepatology (Baltimore, Md.), vol. 76, no. 4, 2022, p. E78, https://doi.org/10.1002/hep.32556.
Warning: These citations may not always be 100% accurate.